Literature DB >> 10640454

Antibodies to squalene in Gulf War syndrome.

P B Asa1, Y Cao, R F Garry.   

Abstract

Gulf War Syndrome (GWS) is a multisystemic illness afflicting many Gulf War-era veterans. The molecular pathological basis for GWS has not been established. We sought to determine whether the presence of antibodies to squalene correlates with the presence of signs and symptoms of GWS. Participants in this blinded cohort study were individuals immunized for service in Desert Shield/Desert Storm during 1990-1991. They included 144 Gulf War-era veterans or military employees (58 in the blinded study), 48 blood donors, 40 systemic lupus erythematosus patients, 34 silicone breast implant recipients, and 30 chronic fatigue syndrome patients. Serum antibodies to squalene were measured. In our small cohort, the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640454     DOI: 10.1006/exmp.1999.2295

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  23 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Authors:  Michael S Petrik; Margaret C Wong; Rena C Tabata; Robert F Garry; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 3.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

Review 4.  Vaccines and autoimmunity.

Authors:  Nancy Agmon-Levin; Ziv Paz; Eitan Israeli; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

5.  Laser vaccine adjuvant for cutaneous immunization.

Authors:  Xinyuan Chen; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 6.  Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Authors:  Gustavo Guimarães Moreira Balbi; Ricardo Azêdo Montes; Verônica Silva Vilela; Marcella Azevedo Borges Andrade; Monisa Martins Nóbrega; Luna Azulay-Abulafia; Roberto Souto da Silva; Evandro Mendes Klumb; Roger Abramino Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.

Authors:  Giuseppe Del Giudice; Elena Fragapane; Roberto Bugarini; Maninder Hora; Thomas Henriksson; Emanuela Palla; Derek O'hagan; John Donnelly; Rino Rappuoli; Audino Podda
Journal:  Clin Vaccine Immunol       Date:  2006-09

8.  Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Authors:  Christopher B Fox; Susan L Baldwin; Malcolm S Duthie; Steven G Reed; Thomas S Vedvick
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

9.  A novel laser vaccine adjuvant increases the motility of antigen presenting cells.

Authors:  Xinyuan Chen; Pilhan Kim; Bill Farinelli; Apostolos Doukas; Seok-Hyun Yun; Jeffrey A Gelfand; Richard R Anderson; Mei X Wu
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.

Authors:  Josette Cadusseau; Nilusha Ragunathan-Thangarajah; Mathieu Surenaud; Sophie Hue; Francois-Jérôme Authier; Romain K Gherardi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.